Global Nausea And Vomiting Treatment Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Global Nausea And Vomiting Treatment Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Nausea And Vomiting Treatment market size was valued at US$ 5723 million in 2024 and is forecast to a readjusted size of USD 8763 million by 2031 with a CAGR of 6.3% during review period.

Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.

United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.Merck & Co. Inc. was the global greatest company in Nausea And Vomiting Treatment industry, with the market Share of 14% , followed by Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro.

This report is a detailed and comprehensive analysis for global Nausea And Vomiting Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Nausea And Vomiting Treatment market size and forecasts, in consumption value ($ Million), 2020-2031

Global Nausea And Vomiting Treatment market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Nausea And Vomiting Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Nausea And Vomiting Treatment market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Nausea And Vomiting Treatment

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Nausea And Vomiting Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Nausea And Vomiting Treatment market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Serotonin Receptor Antagonist

Neurokinin NK1 Receptor Antagonist

Others

Market segment by Application

CINV

PONV

Motion Sickness

Pregnancy

Others

Market segment by players, this report covers

Merck & Co. Inc.

Helsinn Group

Unimed Pharmaceuticals (AbbVie Inc.)

Kyowa Kirin

Sanofi

Qilu Pharma

Teva Pharmaceutical Industries Ltd.

Taiji group

Novartis

Heron Therapeutics

Pharmanovia

Mylan

Duchesnay

GSK

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Nausea And Vomiting Treatment product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Nausea And Vomiting Treatment, with revenue, gross margin, and global market share of Nausea And Vomiting Treatment from 2020 to 2025.

Chapter 3, the Nausea And Vomiting Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Nausea And Vomiting Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Nausea And Vomiting Treatment.

Chapter 13, to describe Nausea And Vomiting Treatment research findings and conclusion.